Vivos Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for VVOS, updated each market day.
VVOS AI Sentiment
AI predicts Vivos Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Vivos Therapeutics, Inc. Common Stock
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Sector
Exchange
Market Cap
$13,712,839
Cap Tier
Employees
109
Headquarters
LITTLETON, CO
Listed Since
Dec. 11, 2020
Website
VVOS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VVOS Volatility
Vivos Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
